The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.
 
Minesh P. Mehta
Employment - Miami Cancer Institute
Stock and Other Ownership Interests - Chimerix
Consulting or Advisory Role - Kazia Therapeutics; Mevion Medical Systems; Novocure; Telix Pharmaceuticals; Xoft; ZappRx
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
(OPTIONAL) Uncompensated Relationships - Xcision Medical Systems
 
Vinai Gondi
Honoraria - UpToDate
Research Funding - ImmunoChem Therapeutics LLC via NIH STTR grant
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)
 
David Roberge
Stock and Other Ownership Interests - AFX Medical; Croton Healthcare; MisoChip
Honoraria - Accuray; AstraZeneca; Novocure; Roche
Consulting or Advisory Role - Novocure; Recordati
Speakers' Bureau - Novocure
Research Funding - IntraOp Medical; Precirix
 
Rosanda Ilic
Travel, Accommodations, Expenses - AstraZeneca
 
Terence Tai Weng Sio
Employment - Mayo Clinic
Consulting or Advisory Role - Novocure
 
Daniel Michael Trifiletti
Consulting or Advisory Role - Boston Scientific
Research Funding - Novocure; Varian Medical Systems
 
Thierry Muanza
No Relationships to Disclose
 
Ana Misir Krpan
No Relationships to Disclose
 
Naren R Ramakrishna
No Relationships to Disclose
 
John B. Fiveash
Research Funding - Varian Medical Systems
Other Relationship - Varian Biopharma (Inst)
 
Philippe Metellus
No Relationships to Disclose
 
Chiachien Jake Wang
Travel, Accommodations, Expenses - BrainLAB
 
Loïc Feuvret
No Relationships to Disclose
 
Christian Freyschlag
Consulting or Advisory Role - Brainlab; SERVIER
Speakers' Bureau - Novocure
 
Tibor Csőszi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Pfizer; Sanofi
 
Paul D. Brown
Honoraria - UpToDate
 
Maciej Harat
Research Funding - Novocure
Travel, Accommodations, Expenses - Brainlab